Medicamen Biotech Ltd

NSE: MEDICAMEQ · BSE: 531146 · Pharmaceuticals & Biotechnology · 14 announcements

Share price: ₹313.25
Market cap: ₹424.9 Cr
Revenue (annual): ₹197.8 Cr
Net profit (annual): ₹9.64 Cr
P/E (TTM): 39.2×Sector 47.3×
Promoter holding: 40.46%+0.00% QoQ
FII holding: 0.07%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Financial Results 4 Annual General Meeting 3 Board Meeting Date 2 Other Announcement 1 Management Change 1 Fund Raise 1 Dividend 1 Board Meeting Outcome 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

27 May 2026 16:02 IST NSE

Board Meeting Outcome

Medicamen Biotech Board Meeting Outcome

Medicamen Biotech Limited's board approved the appointment of Cheena & Associates as internal auditors and SPB & Co as cost auditors. Both appointments are effective April 2026.

Execution: 12 months

Read the filing ↗